| Shareholder | |||
|---|---|---|---|
| Shanghai Shangshi (Group) Co., Ltd. 上海上實(集團)有限公司 | 40.06% | 368.16M | |
| Shanghai Industrial Investment (Holdings) Company Limited 上海實業(集團)有限公司 | 35.03% | 321.96M | |
| New China Life Insurance Company Ltd. | 5.00% | 45.95M | |
| New China Asset Management Co., Ltd. | 5.00% | 45.95M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| Shanghai Shangshi (Group) Co., Ltd. 上海上實(集團)有限公司 | 1.20M | 11.93 | Other event | 368.16M | 40.06% | ||
| Shanghai Shangshi (Group) Co., Ltd. 上海上實(集團)有限公司 | 1.70M | 11.71 | Other event | 359.16M | 39.08% |
This page shows the major shareholders of SH PHARMA (02607) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

